Showing results (791-800 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|October 6, 2018
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factorsSahil Gupta, Arpit Jain, Shahzad Nawaz Syed, et al.
Oncoimmunology|October 6, 2018
Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studiesPeng-Fei Wang, Si-Ying Song, Ting-Jian Wang, et al.
Oncoimmunology|October 6, 2018
Macrophages in radiation injury: a new therapeutic targetLydia Meziani, Eric Deutsch, Michele Mondini
Oncoimmunology|May 4, 2018
Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: Exploring the basis for the genetic control of the tumor microenvironmentGabriela Vera-Lozada, Carolina Minnicelli, Priscilla Segges, et al.
Oncoimmunology|May 4, 2018
Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanismLauren Burkard-Mandel, Rachel O'Neill, Sean Colligan, et al.
Oncoimmunology|May 4, 2018
Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumorsHeming Li, Qing H Meng, Hyangsoon Noh, et al.
Oncoimmunology|May 4, 2018
Protective effects against tumors and infection by interleukin-27 through promotion of expansion and differentiation of hematopoietic stem cells into myeloid progenitorsNaoko Orii, Izuru Mizoguchi, Yukino Chiba, et al.
Oncoimmunology|May 4, 2018
PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS miceTobias Gutting, Christian A Weber, Philip Weidner, et al.
Oncoimmunology|May 4, 2018
Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class IIHoward Y Li, Maria McSharry, Deandra Walker, et al.
Oncoimmunology|June 22, 2012
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infectionAnders Rosén, Ann-Charlotte Bergh, Peter Gogok, et al.
Pageof 379